###begin article-title 0
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 18 23 <span type="species:ncbi:9606">human</span>
Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter
###end article-title 0
###begin p 1
###xml 606 642 606 642 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oupjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
###end p 1
###begin p 2
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 133 134 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 149 150 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 151 152 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 194 195 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 197 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 237 238 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 239 240 223 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 417 418 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 419 420 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 437 445 417 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 488 502 468 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24-hydroxylase</italic>
###xml 504 509 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 630 638 610 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 875 883 855 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 950 951 926 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 952 953 928 929 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1027 1028 999 1000 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1029 1030 1001 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1110 1128 1082 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico/in vitro</italic>
###xml 1618 1619 1586 1587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1620 1621 1588 1589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
The candidate human tumor suppressor gene cyclin C is a primary target of the anti-proliferative hormone 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3], but binding sites for the 1alpha,25(OH)2D3 receptor (VDR), so-called 1alpha,25(OH)2D3 response elements (VDREs), have not yet been identified in the promoter of this gene. We screened various cancer cell lines by quantitative PCR and found that the 1alpha,25(OH)2D3 inducibility of cyclin C mRNA expression, in relationship with the 24-hydroxylase (CYP24) gene, was best in MCF-7 human breast cancer cells. To characterize the molecular mechanisms, we analyzed 8.4 kb of the cyclin C promoter by using chromatin immunoprecipitation assays (ChIP) with antibodies against acetylated histone 4, VDR and its partner receptor, retinoid X receptor (RXR). The histone 4 acetylation status of all 23 investigated regions of the cyclin C promoter did not change significantly in response to 1alpha,25(OH)2D3, but four independent promoter regions showed a consistent, 1alpha,25(OH)2D3-dependent association with VDR and RXR over a time period of 240 min. Combined in silico/in vitro screening identified in each of these promoter regions a VDRE and reporter gene assays confirmed their functionality. Moreover, re-ChIP assays monitored simultaneous association of VDR with RXR, coactivator, mediator and RNA polymerase II proteins on these regions. Since cyclin C protein is associated with those mediator complexes that display transcriptional repressive properties, this study contributes to the understanding of the downregulation of a number of secondary 1alpha,25(OH)2D3-responding genes.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 79 80 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 95 96 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 97 98 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 162 163 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 278 279 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 295 296 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 297 298 285 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 426 431 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 486 487 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 488 489 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 575 576 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 617 618 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 619 620 599 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 753 754 729 730 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 755 756 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 758 759 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 760 761 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 786 794 762 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 796 797 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 962 972 938 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1159 1160 1135 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1300 1301 1276 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1423 1424 1399 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1616 1617 1592 1593 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1622 1623 1598 1599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1721 1723 1697 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 1754 1762 1730 1738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1903 1905 1879 1881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 952 957 <span type="species:ncbi:9606">Human</span>
###xml 962 972 <span type="species:ncbi:7227">Drosophila</span>
The biologically most active vitamin D metabolite, 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3], is essential for mineral homeostasis and skeletal integrity (1), but also has important roles in the control of cell growth and differentiation in normal and malignant tissues (2). 1alpha,25(OH)2D3 levels are tightly controlled by the monooxygenase vitamin D 24-hydroxylase (CYP24), which metabolizes the active hormone. The CYP24 gene is also the most responsive primary 1alpha,25(OH)2D3 target gene and shows at the mRNA level up to 1000-fold inducibility by the hormone (3). Most other known primary 1alpha,25(OH)2D3 target genes are much less responsive and often show an inducibility of 2-fold or less after short-term treatment with 1alpha,25(OH)2D3 (4,5). One of these genes is cyclin C (6). Cyclin C belongs to the cyclin protein superfamily, whose members control cell cycle transitions through activation of cyclin-dependent kinases (CDKs). Human and Drosophila cyclin C proteins share a high degree of homology (72% identity), which suggests an important role for this gene product that is reflected in its conservation in diverse animal species (7). Interestingly, the cyclin C-CDK8 complex was found to be associated with the RNA polymerase II (Pol II) basal transcriptional machinery (8), and is considered as a functional part of those mediator protein (MED) complexes that are involved in gene repression (9). This observation suggests a general role for cyclin C in reducing the transcriptional activity of a cell. Another role of cyclin C, in complex with CDK3, seems to be the regulation of the G0 to G1 transition of the cell cycle through specific phosphorylation of the retinoblastoma protein pRb (10). Moreover, the fact that the cyclin C gene, being located in chromosome 6q21, is deleted in a subset of acute lymphoblastic leukemias, suggests its involvement in tumorigenesis (11).
###end p 4
###begin p 5
###xml 17 18 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 19 20 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 88 89 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 90 91 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 112 113 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 113 114 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 178 180 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 301 303 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 660 662 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 862 864 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1039 1041 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1146 1148 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
The 1alpha,25(OH)2D3 receptor (VDR) is the only nuclear protein that binds 1alpha,25(OH)2D3 with high affinity (Kd = 0.1 nM). Corepressor proteins, such as NCoR, SMRT and Alien (12), link non-liganded, DNA-bound VDR to enzymes with histone deacetylase activity that results in chromatin condensation (13). This provides VDR with intrinsic repressive properties comparable with both retinoic acid and thyroid hormone receptors. Ligand binding to the VDR causes a conformational change within its ligand-binding domain, which results in the replacement of corepressors by coactivator proteins of the p160-family, such as nuclear coactivators (NCoAs) 1, 2 and 3 (14). These coactivators link the ligand-activated VDR to enzymes displaying histone acetyltransferase activity, which results in chromatin relaxation and thereby reversing the action of unliganded VDR (15). In a subsequent step, ligand-activated VDR changes rapidly from interacting with the coactivators of the p160-family to those of the MED complexes, of which cyclin C-CDK8 (16) is a part. The MED complex acts as a bridge from activated VDR to the basal transcriptional machinery (17). In this way ligand-activated VDR executes two tasks, the modification of chromatin and the regulation of transcription.
###end p 5
###begin p 6
###xml 86 87 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 88 89 84 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 247 248 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 249 250 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 357 358 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 360 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 386 388 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 852 854 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 997 999 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 1107 1109 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1397 1399 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 1458 1463 1446 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1470 1472 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 1513 1524 1501 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osteocalcin</italic>
###xml 1531 1533 1519 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 1760 1762 1748 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 1350 1355 <span type="species:ncbi:9606">human</span>
###xml 1452 1457 <span type="species:ncbi:9606">human</span>
###xml 1509 1512 <span type="species:ncbi:10116">rat</span>
An essential prerequisite for the direct modulation of transcription via 1alpha,25(OH)2D3-triggered protein-protein interactions is the location of at least one activated VDR molecule close to the basal transcriptional machinery of a 1alpha,25(OH)2D3-responding gene. This is traditionally achieved through the specific binding of the VDR to a 1alpha,25(OH)2D3 response element (VDRE) (18). The DNA-binding domain of the VDR contacts the major groove of a double-stranded hexameric DNA sequence with the consensus sequence RGKTSA (R = A or G, K = G or T, and S = C or G). In most cases the heterodimeric partner of VDR is the retinoid X receptor (RXR), another nuclear receptor superfamily member, which also contacts DNA. Therefore, simple VDREs are often formed by a direct repeat of two hexameric core binding motifs spaced by 3 nt (DR3-type VDRE) (19). In addition, strong DNA binding of VDR-RXR heterodimers to two hexameric motifs arranged as a direct repeat spaced by 4 nt (DR4-type VDRE) (20) or as an everted repeat with nine intervening nucleotides (ER9-type VDRE) have been described previously (21). Although individual VDREs have been shown to be able to induce transactivation on their own, the presence of multiple VDREs in any given gene promoter suggests that they may act synergistically. A VDRE cluster, containing the most potent human DR3-type VDRE known to date at its core (22), has been reported in the proximal promoter of the human CYP24 gene (23). However, the DR3-type VDRE of the rat osteocalcin gene (24) is the only VDR binding site that is presently understood in its promoter context, where chromatin organization and flanking binding sites for other transcription factors, such as Runx2 and YY1, are taken into consideration (25).
###end p 6
###begin p 7
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
The major protein constituents of chromatin are histones, and the covalent modifications of lysines at their N-terminal tails neutralize their positive charge and thus their attraction for the negatively charged DNA is diminished (26). This influences the packaging grade of the chromatin and regulates the access of transcription factors to their potential binding sites. More than 10 specific modifications of histones are known, but the acetylation of the lysine at position 8 of histone 4 correlates strongly with the activation of chromatin on a promoter preceding the initiation of transcription (27). Therefore, in most cases, the histones associated with active regions of promoters have a higher degree of acetylation at certain positions than in repressed or silent regions. To date, most studies on transcriptional regulation have been concentrated on isolated promoter regions or proximal promoters, where binding sites of nuclear receptors and other transcription factors have been localized (28).
###end p 7
###begin p 8
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 80 81 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 82 83 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 92 93 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 249 257 245 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 413 414 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 415 416 407 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 499 507 491 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 609 610 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 611 612 599 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 799 808 787 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
We have previously identified the human cyclin C gene as a primary 1alpha,25(OH)2D3 target (6). Since neither VDREs nor chromatin packaging of the promoter of this gene was known, we analyzed, in MCF-7 human breast cancer cells, 8.4 kb of the human cyclin C promoter by using chromatin immunoprecipitation assay (ChIP) with antibodies against acetylated histone 4 (AcH4), VDR and RXR. Interestingly, 1alpha,25(OH)2D3 treatment did not change the acetylation status of histone 4 on any region of the cyclin C promoter. In contrast to this finding, up to five promoter regions showed a consistent, 1alpha,25(OH)2D3-dependent association with VDR and RXR over time and in four of these regions re-ChIP assays confirmed the simultaneous association of VDR with RXR, NCoA3, MED1 and Pol II. Furthermore, in silico screening, gel-shift and reporter gene assays identified in each of these four regions a DR3- or DR4-type VDRE.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Cell culture
###end title 10
###begin p 11
###xml 214 215 214 215 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 304 305 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 450 451 446 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 452 453 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 195 201 <span type="species:ncbi:9913">bovine</span>
MCF-7 and MDA-MB453 human breast cancer cells and LNCaP and PC-3 human prostate cancer cell were grown in phenol red-free DMEM and RPMI, respectively, supplemented with 5% charcoal-treated fetal bovine serum, 2 mM l-glutamine, 0.1 mg/ml streptomycin and 100 U/ml penicillin, in a humidified 95% air/5% CO2 incubator. Before mRNA extraction or ChIP assay, the cells were treated at a density of 50-60% confluency for 0-360 min with 10 nM 1alpha,25(OH)2D3 dissolved in ethanol (kindly provided by Dr Lise Binderup, LEO Pharma, Ballerup, Denmark) or vehicle (ethanol, final concentration 0.01%).
###end p 11
###begin title 12
DNA constructs
###end title 12
###begin p 13
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 57 59 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 86 87 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 200 201 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 224 232 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 395 403 391 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 409 434 405 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">atrial natriuretic factor</italic>
###xml 436 439 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANF</italic>
###xml 449 454 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pit-1</italic>
###xml 490 506 486 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thymidine kinase</italic>
###xml 589 597 585 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 686 691 682 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 787 797 783 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">luciferase</italic>
###xml 883 891 879 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 915 924 911 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 959 962 955 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANF</italic>
###xml 971 976 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pit-1</italic>
###xml 988 994 984 990 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGGTCA</bold>
###xml 997 1003 993 999 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGGACA</bold>
###xml 1005 1007 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1015 1021 1011 1017 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGTTCA</bold>
###xml 1025 1031 1021 1027 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGTTCA</bold>
###xml 1033 1035 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 88 92 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
###xml 405 408 <span type="species:ncbi:10116">rat</span>
###xml 445 448 <span type="species:ncbi:10116">rat</span>
###xml 583 588 <span type="species:ncbi:9606">human</span>
###xml 680 685 <span type="species:ncbi:9606">human</span>
###xml 745 750 <span type="species:ncbi:9606">human</span>
###xml 955 958 <span type="species:ncbi:10116">rat</span>
###xml 967 970 <span type="species:ncbi:10116">rat</span>
Full-length cDNAs for human VDR (29) and human RXRalpha (30) were subcloned into the T7/SV40 promoter-driven pSG5 expression vector (Stratagene, La Jolla, CA). The same constructs were used for both T7 RNA polymerase-driven in vitro transcription/translation of the respective cDNAs and for viral promoter-driven overexpression in mammalian cells. Two copies of the VDREs derived from the human cyclin C, rat atrial natriuretic factor (ANF) and rat pit-1 gene promoters were fused with the thymidine kinase promoter driving the firefly luciferase reporter gene. Each fragment of the human cyclin C promoter [from -2176 to -1786 relative to transcription start site (TSS)] and the human CYP24 promoter (from -414 to -173) were cloned by PCR from human genomic DNA and also fused with the luciferase reporter gene. All constructs were verified by sequencing. The core sequences of the cyclin C VDREs are indicated in Figure 4A and the core sequences of the rat ANF and rat pit-1 REs were AGAGGTCATGAAGGACA (31) and GAAGTTCATGAGAGTTCA (32), respectively.
###end p 13
###begin title 14
RNA extraction and real-time quantitative PCR
###end title 14
###begin p 15
###xml 254 256 254 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 559 560 553 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 693 698 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 775 790 745 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;(&#916;&#916;Ct)</sup>
###xml 834 842 784 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 846 851 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 833 852 783 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(<italic>cyclin C</italic> or <italic>CYP24</italic>)</sub>
###xml 858 862 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARP0</italic>
###xml 857 863 807 813 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(<italic>ARP0</italic>)</sub>
###xml 1014 1022 964 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1112 1117 1062 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1207 1209 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1212 1233 1162 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acidic riboprotein P0</italic>
###xml 1235 1239 1185 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARP0</italic>
###xml 1255 1259 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">36B4</italic>
Total RNA and mRNA were extracted using Tri-reagent (Sigma-Aldrich, St Louis, MO) and Oligotex mini mRNA kit (Qiagen, Hilden, Germany), respectively. An aliquot of 100 ng of mRNA was used as a template in cDNA synthesis reaction using 100 pmol of oligodT18 primer in the presence of reverse transcriptase (Fermentas, Vilnius, Lithuania). The reaction was performed for 1 h at 37degreesC. Real-time quantitative PCR was performed in an IQ-cycler (Bio-Rad, Hercules, CA) by using the dye SybrGreen (Molecular Probes, Leiden, The Netherlands). In PCRs, 3 mM MgCl2 was used for all primers. The PCR cycling conditions used were: 40 cycles of 30 s at 95degreesC, 30 s at 58degreesC (62degreesC for CYP24) and 40 s at 72degreesC. Fold inductions were calculated using the formula 2-(DeltaDeltaCt), where DeltaDeltaCt is the , DeltaCt is Ct(cyclin C or CYP24) - Ct(ARP0) and Ct is the cycle at which the threshold is crossed. The gene-specific primer pairs (and product sizes) for the gene analyzed here were as follows: cyclin C gene forward 5'-TGCCTACATGTAGCCTGTGT-3' and reverse 5'-GCTGTAGCTAGAGTTCTGAC-3' (242 bp), CYP24 gene forward 5'-CAAACCGTGGAAGGCCTATC-3' and reverse 5'-AGTCTTCCCCTTCCAGGATCA-3' (70 bp) (33), acidic riboprotein P0 (ARP0, also known as 36B4) control gene forward 5'-AGATGCAGCAGATCCGCAT-3' and reverse 5'-GTGGTGATACCTAAAGCCTG-3' (318 bp). PCR product quality was monitored using post-PCR melt curve analysis.
###end p 15
###begin title 16
ChIP assays
###end title 16
###begin p 17
###xml 387 388 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 405 406 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 413 414 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1843 1844 1813 1814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 2996 2997 2951 2952 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Nuclear proteins were cross-linked to DNA by adding formaldehyde for 15 min directly to the medium to a final concentration of 1%. Cross-linking was stopped by adding glycine to a final concentration of 0.125 M and incubating at room temperature for 5 min on a rocking platform. The medium was removed and the cells were washed twice with ice-cold PBS (140 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4 and 8.1 mM Na2HPO4.2H2O). The cells were collected by scraping in ice-cold PBS supplemented with a protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). After centrifugation, the cell pellets were resuspended in lysis buffer (1% SDS, 10 mM EDTA, protease inhibitors and 50 mM Tris-HCl, pH 8.1) and the lysates were sonicated to obtain DNA fragments of 300-1000 bp in length. Cellular debris was removed by centrifugation and the lysates were diluted 1:10 in ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM NaCl, protease inhibitors and 16.7 mM Tris-HCl, pH 8.1). Non-specific background was removed by incubating the chromatin resuspension with a salmon sperm DNA/protein A agarose slurry (Upstate Biotechnology, Lake Placid, NY) for 30 min at 4degreesC with agitation. The samples were centrifuged and the recovered chromatin solutions were incubated with 5 mul of indicated antibodies overnight at 4degreesC with rotation. The antibody against AcH4 was from Upstate Biotechnology (06-866), whereas antibodies against VDR (sc-1008), RXRalpha (sc-553), NCoA3/RAC3 (sc-7216), MED1/TRAP220 (sc-5334) and phosphorylated Pol II (sc-13583) were obtained from Santa Cruz Biotechnologies (Heidelberg, Germany). The immuno-complexes were collected with 60 mul of protein A agarose slurry (Upstate Biotechnology) for 2 h at 4degreesC with rotation. The beads were pelleted by centrifugation for 1 min at 4degreesC at 100 g and washed sequentially for 5 min by rotation with 1 ml of the following buffers: low-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl and 20 mM Tris-HCl, pH 8.1), high-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 500 mM NaCl and 20 mM Tris-HCl, pH 8.1) and LiCl wash buffer (0.25 mM LiCl, 1% Nonidet P-40, 1% sodium deoxycholate, 1 mM EDTA and 10 mM Tris-HCl, pH 8.1). Finally, the beads were washed twice with 1 ml TE buffer (1 mM EDTA and 10 mM Tris-HCl, pH 8.0). For re-ChIP, the immuno-complexes were eluted by adding 200 mul re-ChIP elution buffer (10 mM DTT) for 30 min at room temperature with rotation, the supernatant was diluted 1:40 in ChIP dilution buffer and the antibody against the second protein of interest was added, the new immuno-complexes were allowed to form by incubating overnight at 4degreesC on a rocking platform, the immuno-complexes were collected by incubating with 60 mul protein A agarose slurry for 2 h at 4degreesC on a rocking platform and finally washed as indicated above. In both cases, the immuno-complexes were then eluted by adding 250 mul elution buffer (1% SDS and 100 mM NaHCO3) and incubated for 15 min at room temperature with rotation. After centrifugation, the supernatant was collected and the elution was repeated. The supernatants were combined and the cross-linking was reversed by adding NaCl to a final concentration of 200 mM and incubated overnight at 65degreesC. The remaining proteins were digested by adding proteinase K (final concentration 40 mug/ml) and incubated for 1 h at 45degreesC. The DNA was recovered by phenol/chloroform/isoamyl alcohol (25:24:1) extractions and precipitated with 0.1 vol of 3 M sodium acetate, pH 5.2 and 2 vol of ethanol using glycogen as a carrier.
###end p 17
###begin title 18
PCR of chromatin templates
###end title 18
###begin p 19
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 107 114 107 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 485 492 473 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
For a complete coverage of the first 8.4 kb of the human cyclin C promoter, 23 primer pairs were designed (Table 1), optimized and controlled by running PCRs with 25 ng genomic DNA (input) as a template. When running immuno-precipitated DNA (output) as a template, 10 ng was used in the optimized conditions for each PCR with the following profile: preincubation for 5 min at 94degreesC, 40 cycles of 30 s denaturation at 95degreesC, 30 s annealing at primer-specific temperature (see Table 1) and 30 s elongation at 72degreesC, with one final incubation for 10 min at 72degreesC. The PCR products were separated by electrophoresis through 2.0% agarose gels supplemented with 0.5 mug/ml ethidium bromide and quantified using a FLA-3000 reader (Fuji, Tokyo, Japan) with Image Gauge software (Fuji).
###end p 19
###begin title 20
Gel-shift analysis
###end title 20
###begin p 21
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 338 340 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 635 643 610 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 860 862 832 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 184 190 <span type="species:ncbi:9986">rabbit</span>
In vitro translated VDR and RXR proteins were generated by coupled in vitro transcription/translation using their respective pSG5-based full-length cDNA expression constructs (29) and rabbit reticulocyte lysate as recommended by the supplier (Promega, Madison, WI). Protein batches were quantified by test translation in the presence of [35S]methionine. The specific concentration of the receptor proteins was adjusted to approximately4 ng/mul (10 ng corresponds to approximately0.2 pmol) after taking the individual number of methionine residues per protein into account. Gel-shift assays were performed with 10 ng of the appropriate in vitro translated proteins. The proteins were incubated for 15 min in a total volume of 20 mul binding buffer (150 mM KCl, 1 mM DTT, 0.2 mug/mul poly(dI-dC), 5% glycerol and 10 mM HEPES, pH 7.9). Constant amounts (1 ng) of 32P-labeled double-stranded oligonucleotides (50 000 c.p.m.) corresponding to one copy of a dimeric RE were then added and incubation was continued for 20 min at room temperature. Protein-DNA complexes were resolved by electrophoresis through 8% non-denaturing polyacrylamide gels in 0.5x TBE (45 mM Tris, 45 mM boric acid and 1 mM EDTA, pH 8.3) and quantified on a FLA-3000 reader using Image Gauge software.
###end p 21
###begin title 22
Transfection and luciferase reporter gene assays
###end title 22
###begin p 23
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 302 303 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 332 333 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 334 335 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 336 337 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 714 715 705 706 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 716 717 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 149 155 <span type="species:ncbi:9913">bovine</span>
###xml 267 272 <span type="species:ncbi:9606">human</span>
###xml 633 639 <span type="species:ncbi:9913">bovine</span>
MCF-7 cells were seeded into six-well plates (105 cells/ml) and grown overnight in phenol red-free DMEM supplemented with 5% charcoal-stripped fetal bovine serum. Plasmid DNA containing liposomes were formed by incubating a reporter plasmid and expression vector for human VDR (each 1 mug) with 10 mug N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate (DOTAP) (Roth, Karlsruhe, Germany) for 15 min at room temperature in a total volume of 100 mul. After dilution with 900 mul phenol red-free DMEM, the liposomes were added to the cells. Phenol red-free DMEM supplemented with 500 mul of 15% charcoal-stripped fetal bovine serum was added 4 h after transfection. At this time, 100 nM 1alpha,25(OH)2D3 or solvent was also added. The cells were lysed 16 h after the onset of stimulation using the reporter gene lysis buffer (Roche Diagnostics) and the constant light signal luciferase reporter gene assay was performed according to the supplier's recommendation (Canberra-Packard, Groningen, The Netherlands). The luciferase activities were normalized with respect to protein concentration and induction factors were calculated as the ratio of luciferase activity of ligand-stimulated cells to that of solvent controls.
###end p 23
###begin title 24
RESULTS
###end title 24
###begin title 25
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
Basal expression of cyclin C and CYP24 in different cancer cell lines
###end title 25
###begin p 26
###xml 60 61 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 62 63 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 78 86 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 91 96 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 181 185 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARP0</italic>
###xml 286 295 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 484 492 480 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 636 641 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 670 678 654 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 770 775 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 948 956 932 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 961 966 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1010 1018 994 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1109 1114 1093 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 257 262 <span type="species:ncbi:9606">human</span>
The basal expression levels of the two primary 1alpha,25(OH)2D3 target genes, cyclin C and CYP24, were monitored by real-time quantitative PCR in relationship with the control gene ARP0 in MCF-7 and MDA-MB453 human breast cancer cells and in LNCaP and PC-3 human prostate cancer cells (Figure 1A). MCF-7 and LNCaP are less agressive estrogen- and testosterone-dependent cell lines, respectively, while MDA-MB453 and PC-3 are sex-hormone-insensitive cells. The basal expression of the cyclin C gene was found to be comparable in MCF-7 and LNCaP cells and was approximately30 000-fold higher than that of the basal mRNA expression of the CYP24 gene. The expression of the cyclin C gene was nearly 10-fold higher in MDA-MB453 cells than in MCF-7 and LNCaP cells, while the CYP24 mRNA level was <3-fold elevated in MDA-MB453 cells compared with the two other cell lines. This results in a nearly 100 000-fold difference in the basal mRNA expression of cyclin C and CYP24 in these cells. Finally, in PC-3 cells the cyclin C mRNA level was found to be 3-fold higher than that in both MCF-7 and LNCaP cells, but the CYP24 gene expression was 10-fold elevated. This means that the two genes differ in their expression only by a factor of 10 000-fold in this cell line.
###end p 26
###begin title 27
###xml 13 14 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 15 16 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 33 41 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 46 51 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
1alpha,25(OH)2D3 inducibility of cyclin C and CYP24 in different cancer cell lines
###end title 27
###begin p 28
###xml 65 66 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 67 68 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 103 111 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 116 121 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 182 191 178 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 232 240 228 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 409 414 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 665 673 661 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 721 726 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 771 779 767 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 876 880 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARP0</italic>
###xml 999 1007 983 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1028 1033 1012 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1071 1079 1055 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1107 1116 1091 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1C</xref>
###xml 1251 1256 1235 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1510 1511 1490 1491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1512 1513 1492 1493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1537 1545 1517 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1531 1536 <span type="species:ncbi:9606">human</span>
All four cell lines were treated for 2 h with 10 nM 1alpha,25(OH)2D3 and the fold change of normalized cyclin C and CYP24 mRNA was measured in relationship with the solvent control (Figure 1B). After this short-term stimulation the cyclin C mRNA level was found to be 1.8-fold upregulated in MCF-7 cells, 1.6-fold in LNCaP cells, 1.2-fold in MDA-MB453 cells and slightly reduced in PC-3 cells. In comparison, CYP24 gene expression was increased to 3.9-fold in MCF-7 cells, 6.1-fold in LNCaP cells, 3.3-fold in MDA-MB453 cells and 10.8-fold in PC-3 cells within the same time period. This means that MCF-7 cells showed not only the highest absolute induction of the cyclin C gene, but also monitor, in comparison with the CYP24 gene, the highest relative induction. Since cyclin C mRNA molecules are more abundant (reflected in the high-basal level of the mRNA relative to the ARP0 control gene), we estimate that MCF-7 cells synthesized within the 2 h stimulation period approximately7600-fold more cyclin C mRNA molecules than CYP24 mRNA molecules. A 6 h time course of cyclin C expression in MCF-7 cells (Figure 1C) suggests that the upregulation of the gene was very transient and showed a maximum after 2 h stimulation. This is in contrast to the CYP24 gene, which showed a steady increase in mRNA amount up to >400-fold induction after 6 h stimulation (data not shown). Taken together, the real-time quantitative PCR results suggest that MCF-7 cells are most suited for investigations of the 1alpha,25(OH)2D3-induction of the human cyclin C promoter.
###end p 28
###begin title 29
###xml 6 14 6 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
Whole cyclin C promoter screening for histone 4 acetylation levels
###end title 29
###begin p 30
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 208 209 204 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 210 211 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 380 388 376 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 395 402 391 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 473 478 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 520 522 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 653 655 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1105 1106 1085 1086 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1107 1108 1087 1088 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1323 1332 1303 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 1388 1396 1368 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1431 1436 1411 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1723 1731 1703 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1781 1786 1761 1766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1988 1997 1968 1977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 2050 2055 2030 2035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 2115 2123 2095 2103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 2389 2397 2369 2377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 2492 2500 2472 2480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 2599 2600 2575 2576 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2601 2602 2577 2578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 2604 2613 2580 2589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 2664 2669 2640 2645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 2828 2836 2804 2812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 2877 2882 2853 2858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 2950 2951 2922 2923 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2952 2953 2924 2925 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 3012 3020 2984 2992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 3079 3088 3051 3060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 786 791 <span type="species:ncbi:9606">human</span>
###xml 1025 1031 <span type="species:ncbi:9913">bovine</span>
We hypothesized that a transient upregulation of the cyclin C gene should result in dynamic changes in the chromatin activation state on a wider region of the promoter of the gene in response to 1alpha,25(OH)2D3 stimulation. In order to test this hypothesis, we designed 23 overlapping primer pairs that cover evenly the first 8.4 kb of chromosomal DNA upstream of the TSS of the cyclin C gene (Table 1). As a reference, a primer pair covering the proximal promoter of the CYP24 gene, containing the known VDRE cluster (34), was used. To minimize the number of primers in repetitive sequences, we employed the web-based CENSOR server screening service (35) to identify repetitive sequences in the promoter sequence. We determined that the repetitive sequence content of this segment of human chromosome 6 is approximately46%. The remaining 54% unique sequence was used to design the overlapping PCR primer pairs. Chromatin was extracted from MCF-7 cells that were grown overnight in the presence of 5% charcoal-treated fetal bovine serum, stimulated for 0, 30, 60, 120 and 180 min with 10 nM 1alpha,25(OH)2D3 and then cross-linked for 15 min in the presence of formaldehyde. ChIP assays were performed using an antibody against AcH4 and representative agarose gels of the PCR products from all treatment times are shown in Figure 2A. Comparable detection sensitivity for the 23 different cyclin C promoter regions and the proximal CYP24 promoter was demonstrated by the representative PCR products that were obtained using DNA liberated from the recovered chromatin by reverse cross-linking (input lane). PCR products obtained with AcH4-enriched chromatin visualized the acetylation status of each of the 23 regions of the cyclin C promoter in comparison with that of the proximal CYP24 promoter. Cell treatment, chromatin extraction and PCR were performed at least six times and the basal histone 4 acetylation level was quantified in relationship with their respective chromatin input (Figure 2B). Interestingly, while the proximal promoter of the CYP24 gene showed a low acetylation level, all 23 regions of the cyclin C promoter displayed significantly more association with AcH4. The latter was highest at the TSS and within the first 617 bp of the promoter (regions 1 and 2) and lowest at promoter regions 3, 10 and 11. However, the histone 4 acetylation level of all regions of the cyclin C promoter did not vary more than by a factor of 2. Moreover, for each of the 23 regions of the cyclin C promoter the histone 4 acetylation level did not change significantly in response to 1alpha,25(OH)2D3 (Figure 2A). In contrast, AcH4 association with the proximal CYP24 promoter showed a steady increase after 60 min ligand stimulation. In summary, the ChIP assay results demonstrate that the histone 4 acetylation level of the cyclin C promoter is, in contrast to that of the CYP24 promoter, not suited to monitor regulatory effects of 1alpha,25(OH)2D3. However, the high-basal levels reflect the fact that the cyclin C gene is highly transcribed in the absence of the hormone (Figure 1A).
###end p 30
###begin title 31
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
VDR location on the cyclin C promoter
###end title 31
###begin p 32
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 101 110 101 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 174 175 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 176 177 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 635 640 631 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 891 892 883 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 893 894 885 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1045 1046 1033 1034 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1047 1048 1035 1036 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1074 1082 1062 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1087 1092 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1167 1175 1155 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
We next screened the whole cyclin C promoter for regions that precipitated with anti-VDR antibodies (Figure 3A). Over a stimulation period of 240 min with 10 nM 1alpha,25(OH)2D3, VDR association centered at promoter regions 1, 6, 16, 20 and 23. These regions were separated by regions 2-4, 8-14, 18 and 22, which showed no or only very faint association with VDR. Since a portion of the chromatin template fragments were significantly larger than the amplified PCR products, the signals obtained at regions 5 and 7, 15 and 17, and 19 and 21 are interpreted as flanking effects. Promoter regions 1, 6, 20 and 23 as well as the proximal CYP24 promoter showed a significant increase in VDR association over time with a maximum between 60 and 180 min. In contrast, promoter region 16 displayed constitutive association with VDR, which was not significantly increased in response to 1alpha,25(OH)2D3. Taken together, the ChIP assay results indicate that, in contrast to histone 4 acetylation, VDR association is better suited to monitor 1alpha,25(OH)2D3-dependent changes of the cyclin C and CYP24 promoters. These results also indicate that up to five regions within the cyclin C promoter are nucleation points for activated VDR.
###end p 32
###begin title 33
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
RXR location on the cyclin C promoter
###end title 33
###begin p 34
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 178 179 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 180 181 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 241 250 237 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 324 332 320 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 415 424 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 943 951 939 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1037 1038 1029 1030 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1039 1040 1031 1032 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1140 1145 1132 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
We next screened the whole cyclin C promoter with ChIP assays using an antibody against the VDR partner receptor RXR over a stimulation period of 240 min with 10 nM 1alpha,25(OH)2D3 to identify potential VDR-RXR heterodimer binding regions (Figure 3B). From the results, it was found that the pattern of RXR location on the cyclin C promoter was nearly identical to the pattern obtained with the anti-VDR antibody (Figure 3A). RXR association centered at promoter regions 1, 6, 16, 19 and 23 that were isolated from each other by the non-associating regions 2-4, 8-14, 17, 21 and 22. Signals observed at regions 5, 7, 15 and 18 might be explained by being regions that flank positive regions. The only difference between the RXR and VDR association patterns was observed at regions 18-21, where the RXR patterns suggest region 19 as the center while the VDR pattern suggested region 20. In general, RXR binding to the different regions of the cyclin C promoter showed to be rather constitutive and no significant effects of 1alpha,25(OH)2D3 on the association level of RXR with these regions could be detected. In contrast, on the proximal CYP24 promoter RXR binding displayed a clear maximum between 60 and 120 min. In summary, RXR location fits almost perfectly VDR location and suggests that promoter regions 1, 6, 16, 19/20 and 23 are able to bind VDR-RXR heterodimers.
###end p 34
###begin title 35
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
Identification of VDREs on cyclin C promoter
###end title 35
###begin p 36
###xml 55 63 55 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 188 197 188 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 235 243 235 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 749 758 749 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 82 87 <span type="species:ncbi:9606">human</span>
The ChIP assays with anti-VDR and anti-RXR antibodies (Figure 3) suggest that the human cyclin C promoter may contain up to five VDREs. In order to challenge this prediction, we performed in silico screening of the first 8.4 kb of the cyclin C promoter for DR3-, DR4- and ER9-type response elements (REs) with the consensus sequence RGKTSA allowing for one mismatch per hexameric sequence. Applying this rule we found nine DR3-type REs, eight DR4-type REs and two ER9-type REs. From these 19 REs, 6 were found in the area of the VDR-RXR binding promoter regions 6, 16, 19/20 and 23. These were two DR3-type REs (RE7 and RE8 in regions 20 and 23, respectively) and four DR4-type REs (RE2, RE5, RE6 and RE9 in regions 6, 16, 19 and 23, respectively) (Figure 4A). From the remaining 13 putative VDREs outside of these 5 promoter regions, only the sequences of the 2 DR3-type REs 1 and 3 (in regions 3 and 11, respectively) and 1 DR4-type RE4 (close to region 11) were found interesting enough for further investigations. Surprisingly, no high-quality putative RE was found in region 1 and no promising ER9-type RE in the whole promoter area. Although RE8 and RE9 in region 23 form a cluster, the constituting DR3- and DR4-type REs were tested individually to examine their relative contribution to potential VDR-RXR binding.
###end p 36
###begin p 37
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 145 154 145 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 1034 1042 1034 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1096 1105 1096 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1106 1114 1106 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1152 1160 1152 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1185 1194 1185 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 342 347 <span type="species:ncbi:9606">human</span>
On all of the nine putative VDREs, gel-shift assays were performed with in vitro translated VDR and RXR protein, either alone or in combination (Figure 4B), under conditions identical to our earlier DR3-type VDRE comparative study (22). RE2 bound 2.87-fold more effective VDR-RXR heterodimers than the reference DR3-type VDRE of the proximal human CYP24 promoter (23), while the relative binding of VDR-RXR to RE5, RE7 and RE8 was only 4, 27 and 16%, respectively, of the reference element. Neither VDR nor RXR homodimers was observed on any of the 10 tested REs. The binding strength of the DR4-type RE2 in region 6 belongs to the strongest known VDRE class (i.e. type I), while the DR4-type RE5 in region 16, the DR3-type RE7 in region 20 and the DR3-type RE8 in region 23 are class II-type VDREs (22). In contrast, the isolated REs 1, 3, 4, 6 and 9 did not show any binding of VDR-RXR heterodimers. This suggests that the additional 10, more degenerate, putative REs outside of regions 3, 6, 11, 16, 19/20 and 23 may not allow any in vitro binding of VDR-RXR heterodimers. Taken together, our in silico/in vitro scanning for functional VDREs in the cyclin C promoter (summarized in Figure 4C) indicated that from 19 putative DNA-binding sites of the VDR only REs 2, 5, 7 and 8 in regions 6, 16, 20 and 23, respectively, showed significant VDR-RXR heterodimer binding. Since these four regions also show ligand-dependent association with VDR in ChIP assays, we conclude that the VDREs are responsible for the VDR and RXR association.
###end p 37
###begin title 38
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
Functionality of cyclin C VDREs in MCF-7 cells
###end title 38
###begin p 39
###xml 113 129 113 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thymidine kinase</italic>
###xml 159 169 159 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">luciferase</italic>
###xml 263 264 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 265 266 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 268 277 264 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 302 305 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANF</italic>
###xml 332 337 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pit-1</italic>
###xml 395 397 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 499 507 495 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 298 301 <span type="species:ncbi:10116">rat</span>
###xml 328 331 <span type="species:ncbi:10116">rat</span>
In order to test the functionality of the REs 2, 5, 7 and 8, two copies of each of these REs were fused with the thymidine kinase promoter driving the firefly luciferase reporter gene, transfected into MCF-7 cells and stimulated for 16 h with 100 nM 1alpha,25(OH)2D3 (Figure 5A). Two copies of the rat ANF DR3-type VDRE and the rat pit-1 DR4-type RE, which are the best REs in their categories (22), mediated a 17.4- and 26.2-fold induction of reporter gene activity, respectively. The VDREs of the cyclin C promoter did not show that high a response to ligand treatment, but the 18.8-, 3.0-, 8.3- and 5.6-fold inductions after ligand stimulation for REs 2, 5, 7 and 8, respectively, are still representing 72, 17, 48 and 15% of the inducibility of their respective DR4- and DR3-type reference VDREs.
###end p 39
###begin p 40
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 331 332 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 333 334 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 336 345 332 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 451 456 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 503 512 499 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 710 718 706 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 830 835 826 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 126 131 <span type="species:ncbi:9606">human</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 824 829 <span type="species:ncbi:9606">human</span>
The functionality of RE2 in its natural promoter context was tested by analyzing the inducibility of a 390 bp fragment of the human cyclin C promoter (from -2176 to -1786) in MCF-7 cells measured by luciferase reporter gene assays. We obtained a 8.4-fold induction of luciferase activity after stimulation with 100 nM 1alpha,25(OH)2D3 (Figure 5B). This is very much comparable with the 8.9-fold induction of a reference promoter fragment of the human CYP24 promoter containing the DR3-type VDRE used in Figure 4B. In summary, reporter gene assays confirmed the functionality of the DR3- and DR4-type VDREs 2, 5, 7 and 8 in promoter regions 6, 16, 20 and 23, respectively, and the most potent VDRE, RE2, of the cyclin C promoter showed in its natural promoter context the same ligand inducibility as the DR3-type VDRE of the human CYP24 promoter.
###end p 40
###begin title 41
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
Co-localization of VDR and RXR on cyclin C promoter regions
###end title 41
###begin p 42
###xml 126 134 126 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 466 474 466 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 650 658 650 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 720 725 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 995 996 991 992 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 997 998 993 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1010 1018 1006 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
An additional test for the functionality of the VDREs in the chromatin context of MCF-7 cells was performed by re-ChIP assay (Figure 6). In this assay, first the anti-VDR antibody and then antibodies against RXR, NCoA3, MED1 or phosphorylated Pol II were used for immuno-precipitation, so that the enriched chromatin templates should have been associated with both VDR and its partner proteins at the same time. From this double-fractionated chromatin template, the cyclin C promoter regions 6, 16, 20 and 23 were amplified, but not the negative control region 11. The association of VDR with its partner proteins showed an individual profile on the cyclin C promoter regions 6, 16, 20 and 23 as well as on the proximal CYP24 promoter in their relative strength, but most of them showed their maximum at the time point 60 min after ligand treatment. In summary, re-ChIP assays confirmed the simultaneous association of VDR with RXR, NCoA3, MED1 or phosphorylated Pol II on all four 1alpha,25(OH)2D3-responsive cyclin C promoter regions.
###end p 42
###begin title 43
DISCUSSION
###end title 43
###begin p 44
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 99 100 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 101 102 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 108 116 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 153 154 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 155 156 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 260 261 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 262 263 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 447 455 435 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 472 473 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 474 475 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 559 560 539 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 561 562 541 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 686 687 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 689 690 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 703 705 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 1246 1248 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1325 1326 1305 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1370 1372 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 1648 1656 1628 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1687 1695 1667 1675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyclin C</italic>
###xml 1761 1762 1741 1742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1764 1766 1744 1746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 1834 1836 1814 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 1891 1899 1871 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1944 1945 1920 1921 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1946 1947 1922 1923 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1967 1976 1943 1952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1C</xref>
This study describes a deeper understanding of the regulation of the cyclin C gene by 1alpha,25(OH)2D3. The cyclin C gene is an interesting 1alpha,25(OH)2D3-responding gene, since its function is not linked to the classical endocrine functions of 1alpha,25(OH)2D3, such as the regulation of calcium homeostasis and bone mineralization, but to the regulation of cellular growth. Being identified as a member of the cyclin family, the regulation of cyclin C by 1alpha,25(OH)2D3 should provide a more detailed understanding of the mechanisms of how 1alpha,25(OH)2D3 regulates cellular functions, such as proliferation, differentiation and apoptosis. However, despite some function in the G0-G1 transition (10), the main function of cyclin C protein seems to be acting as a component of MED complexes. This suggests that cyclin C regulates the general transcription rate rather than the cell cycle. Therefore, it is possible that the effects that cyclin C has on the cell cycle are secondary in nature and derive from an effect on the build up of other products involved more intimately in cell cycle regulation. Interestingly, cyclin C has been reported to be contained only in those MED complexes that have a transcriptionally repressive function (16). The cyclin C-CDK8 complex phosphorylates the C-terminal domain of Pol II (8) and the basal transcription factor TFIIH (36) and both of the phosphorylations terminate transcription. Nevertheless, the impact of a gene that represses mRNA transcription in general, is at least as high as that of a gene that influences the cell cycle. In the context of both functions the transient expression of the cyclin C is important and makes sense. Cyclin C mRNA accumulates periodically during the cell cycle, peaking in G1 (37). Moreover, cyclin C protein was shown to have a half-life of 4 h (38) and in this study we have shown that the increase in cyclin C mRNA expression in response to 1alpha,25(OH)2D3 is very transient (Figure 1C). In contrast, for an enzyme, such as the monooxygenase CYP24, it is important to stay active for a longer time period and its expression should be independent of the cell cycle.
###end p 44
###begin p 45
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 164 165 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 166 167 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 248 249 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 250 251 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 389 394 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 549 558 541 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 602 610 594 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 663 668 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 675 684 667 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 800 809 792 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1000 1007 984 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cylin C</italic>
###xml 1033 1041 1017 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1093 1095 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 1129 1137 1109 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1260 1268 1240 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 1326 1327 1302 1303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1328 1329 1304 1305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1395 1400 1371 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1431 1439 1407 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1450 1459 1426 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 1523 1528 1499 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1582 1590 1558 1566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1654 1655 1626 1627 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1656 1657 1628 1629 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1707 1715 1679 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1815 1820 1787 1792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 994 999 <span type="species:ncbi:9606">human</span>
The reference gene of this study, CYP24, is the most responsive primary VDR target gene and is expressed in numerous tissues. It has a special role in 1alpha,25(OH)2D3 signaling, because its protein product leads to the degradation of 1alpha,25(OH)2D3 and, therefore, the eventual extinction of the transcriptional signal. VDR-RXR heterodimers are the central transcription factors on the CYP24 promoter, so that it is not surprising that the basal expression of the gene in the absense of an activating signal for VDR-RXR heterodimers is very low (Figure 1A). In contrast, the basal expression of the cyclin C gene is 10 000-100 000-fold higher than that of the CYP24 gene (Figure 1A), suggesting that transcription factors other than VDR-RXR heterodimers contribute to the activity of the gene. An in silico screening for putative transcription factor binding sites highlighted each two nuclear factor kappaB (NFkappaB) and AP-1 binding sites located between positions -5800 and -6800 of the human cylin C promoter. Interestingly, cyclin C was listed recently as a NFkappaB responding gene (39). The high-basal activity of the cyclin C gene is also demonstrated by the overall high level of histone 4 acetylation throughout the whole 8.4 kb of its promoter (Figure 2). Moreover, the fact, that a treatment with 1alpha,25(OH)2D3 is visible on the level of histone 4 acetylation of the proximal CYP24 promoter but not on the whole cyclin C promoter (Figure 2A), confirms the dominating role of VDR-RXR heterodimers for the CYP24 gene regulation and relativizes their impact for the cyclin C gene. However, since the behavior of most primary 1alpha,25(OH)2D3-responding genes resembles more than that of the cyclin C gene, with a modulation of the mRNA amount by a factor of only 1.5-2.0, the strong response of the CYP24 gene has to be considered as an exception.
###end p 45
###begin p 46
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS2</italic>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 301 309 301 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 470 478 470 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 500 501 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 502 503 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 935 937 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
A number of nuclear receptor target gene promoters, such as the CYP24 or the estrogen-induced pS2 gene (28), appear to have one dominating RE and the analysis of the chromatin status has mostly concentrated on these core promoter regions. In this study, we also found one strong VDRE (RE2) within the cyclin C promoter, which in addition is the RE closest to the TSS (position -2100). This VDRE may be considered as sufficient for understanding the full response of the cyclin C gene to 1alpha,25(OH)2D3. However, in addition to promoter region 6, in which RE2 is located, ChIP screening with anti-VDR and anti-RXR antibodies consistently identified four additional VDR-RXR associating regions, three of which contain classical VDREs. The ChIP signal obtained for region 1, which contains the TSS may be due to the interaction of the VDR-RXR bound to the VDREs at promoter regions 6, 16, 20 and 23 via traditional 'DNA looping model' (40), i.e. a false positive result.
###end p 46
###begin p 47
###xml 19 27 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 121 129 121 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 377 385 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 530 538 530 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 683 688 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 903 909 903 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2B6</italic>
###xml 914 920 914 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 1041 1049 1041 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 679 682 <span type="species:ncbi:10116">rat</span>
Accepting that the cyclin C promoter has up to four functional VDREs, raises the question of their purpose. Although the in vitro DNA-binding affinity of VDR-RXR heterodimers to REs 5, 7 and 8 and their inducibility in MCF-7 cells was clearly lower than that of RE2, on chromatin level all four VDRE-containing promoter regions show equal association strength with VDR or RXR (Figure 3). Other transcription factors that bind in the vicinity stabilize a VDR-RXR heterodimer to a VDRE, which is physically weak under the stringent in vitro binding conditions. Such a phenomenon has already been described to explain the binding of VDR-RXR heterodimers to the proximal VDRE of the rat CYP24 gene promoter (41). Alternatively, the four distinct REs could come together simultaneously and work co-operatively as has been already observed with the RE clusters of other nuclear receptor target genes, such as CYP2B6 and CYP3A4 (42). Thus, REs can act synergistically in the activation of the respective genes, which could also be the case for the cyclin C promoter.
###end p 47
###begin p 48
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pit-1</italic>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 792 800 792 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 909 918 909 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 983 991 983 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1071 1074 1071 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANF</italic>
###xml 1081 1083 1081 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1098 1109 1098 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osteopontin</italic>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 1136 1144 1136 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1334 1342 1334 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 1353 1358 1353 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 1507 1508 1503 1504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1509 1510 1505 1506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 329 332 <span type="species:ncbi:10116">rat</span>
###xml 786 791 <span type="species:ncbi:9606">human</span>
###xml 878 883 <span type="species:ncbi:9606">human</span>
###xml 949 954 <span type="species:ncbi:9606">human</span>
###xml 977 982 <span type="species:ncbi:9606">human</span>
###xml 1067 1070 <span type="species:ncbi:10116">rat</span>
###xml 1092 1097 <span type="species:ncbi:10090">mouse</span>
###xml 1172 1177 <span type="species:ncbi:9606">human</span>
The strong DR4-type VDRE at position -2100 relative to the TSS, RE2, belongs to the most potent known VDR-RXR heterodimer binding sites. Under the same stringent evalution criteria as applied in a comparative study of all known VDREs (22), the VDRE shows 25% of the VDR-RXR heterodimer binding strength of the DR4-type RE of the rat pit-1 promoter (32) and even 72% of its inducibility in MCF-7 cells. The latter RE is formed by two perfect hexameric half-site with optimized 5'-flanking sequences (43) and has served as a reference in a number of comparative nuclear receptor studies (22,43,44), but its general physiological impact can be questioned, since it is located in a chromatin region that is only active during a short time in embryonic development. The DR4-type VDRE of the human cyclin C promoter is nearly 3-fold more potent compared with the DR3-type VDRE of the human CYP24 proximal promoter (Figure 4B), which is presently the best human VDRE (22). RE2 of the human cyclin C promoter is also comparable in its strength with the DR3-type VDREs of the rat ANF gene (31) or the mouse osteopontin gene (45). This makes the cyclin C VDRE the most potent known human VDRE. Therefore, it is likely that in future it will serve as a reference to a number of studies on novel VDREs. Moreover, the examples of the VDREs of the cyclin C gene, the CYP24 gene and other VDR target genes demonstrate that equally potent VDR-RXR heterodimer binding ability can result in completely different 1alpha,25(OH)2D3 inducibility of the respective gene. Therefore, as an additional parameter for a prediction of ligand responsiveness the basal activity of the respective gene's promoters has to be taken into account.
###end p 48
###begin p 49
###xml 58 59 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 60 61 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 155 156 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 157 158 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 212 213 204 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 214 215 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 349 350 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 351 352 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 369 377 357 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 440 442 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 529 530 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 531 532 515 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
The mechanisms of downregulation of genes by 1alpha,25(OH)2D3 is largely not understood, although microarrays and other gene expression profiling methods (4,5) suggest that approximately half of all 1alpha,25(OH)2D3-responding genes are downregulated by the hormone. In this respect, the finding that the protein product of the primary 1alpha,25(OH)2D3-responding gene cyclin C is a component of transcriptionally repressive MED complexes (16), may provide a mechanism to explain how the downregulation of secondary 1alpha,25(OH)2D3-responding genes is mediated. Experiments investigating this hypothesis are currently underway in our laboratory.
###end p 49
###begin p 50
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 99 100 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 101 102 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 255 263 251 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 498 499 490 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 500 501 492 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
In conclusion, our study provided insight into the regulation of the cyclin C gene by 1alpha,25(OH)2D3. We demonstrated that whole promoter ChIP screening with anti-VDR and anti-RXR antibodies is suitable for RE identification, found within 8.4 kb of the cyclin C promoter one strong and three weaker VDREs and monitored in MCF-7 cells the association of VDR-RXR with the promoter regions containing these VDREs. This may help to understand the downregulation of a number of secondary 1alpha,25(OH)2D3-responding genes with an impact on cellular growth, differentiation and apoptosis.
###end p 50
###begin p 51
###xml 57 58 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 59 60 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
We would like to thank Dr Lise Binderup for 1alpha,25(OH)2D3 and Dr Thomas W. Dunlop for critical reading of the manuscript. Grants from the Academy of Finland, the Finnish Cancer Organisation and the Finnish Technology Agency TEKES (all to C.C.) supported this research. Funding to pay the Open Access publication charges for this article was provided by the Academy of Finland.
###end p 51
###begin p 52
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 52
###begin title 53
REFERENCES
###end title 53
###begin article-title 54
Vitamin D: more than a 'bone-a-fide' hormone
###end article-title 54
###begin article-title 55
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis
###end article-title 55
###begin article-title 56
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 66 69 <span type="species:ncbi:10116">rat</span>
Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo
###end article-title 56
###begin article-title 57
Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray
###end article-title 57
###begin article-title 58
###xml 77 78 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells
###end article-title 58
###begin article-title 59
###xml 50 51 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Cyclin C is a primary 1alpha,25-dihydroxyvitamin D3 responding gene
###end article-title 59
###begin article-title 60
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II
###end article-title 60
###begin article-title 61
Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II
###end article-title 61
###begin article-title 62
A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II
###end article-title 62
###begin article-title 63
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
Cyclin C/cdk3 promotes Rb-dependent G0 exit
###end article-title 63
###begin article-title 64
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors
###end article-title 64
###begin article-title 65
Co-repressors 2000
###end article-title 65
###begin article-title 66
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
VDR-Alien: a novel, DNA-selective vitamin D3 receptor-corepressor partnership
###end article-title 66
###begin article-title 67
The SRC family of nuclear receptor coactivators
###end article-title 67
###begin article-title 68
Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1)
###end article-title 68
###begin article-title 69
Characterization of mediator complexes from HeLa cell nuclear extract
###end article-title 69
###begin article-title 70
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
###end article-title 70
###begin article-title 71
###xml 28 29 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Gene regulation by vitamin D3
###end article-title 71
###begin article-title 72
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
The vitamin D3 receptor in the context of the nuclear receptor superfamily: the central role of retinoid X receptor
###end article-title 72
###begin article-title 73
Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements
###end article-title 73
###begin article-title 74
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity
###end article-title 74
###begin article-title 75
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
All natural DR3-type vitamin D response elements show a similar functionality in vitro
###end article-title 75
###begin article-title 76
###xml 49 50 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 15 20 <span type="species:ncbi:9606">human</span>
Cloning of the human 1alpha,25-dihydroxyvitamin D3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements
###end article-title 76
###begin article-title 77
###xml 84 85 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 116 119 <span type="species:ncbi:10116">rat</span>
The Runx2 transcription factor plays a key role in the 1alpha,25-dihydroxy vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells
###end article-title 77
###begin article-title 78
###xml 88 89 84 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 114 117 <span type="species:ncbi:10116">rat</span>
Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells
###end article-title 78
###begin article-title 79
Translating the histone code
###end article-title 79
###begin article-title 80
###xml 152 157 <span type="species:ncbi:9606">human</span>
Distinctive patterns of histone H4 acetylation are associated with defined sequence elements within both heterochromatic and euchromatic regions of the human genome
###end article-title 80
###begin article-title 81
Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter
###end article-title 81
###begin article-title 82
Two nuclear signalling pathways for vitamin D
###end article-title 82
###begin article-title 83
###xml 2 5 2 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cis</italic>
9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRalpha
###end article-title 83
###begin article-title 84
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 93 96 <span type="species:ncbi:10116">rat</span>
Functional characterization of a 1,25-dihydroxyvitamin D3 receptor binding site found in the rat atrial natriuretic factor promoter
###end article-title 84
###begin article-title 85
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pit-1</italic>
A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene
###end article-title 85
###begin article-title 86
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
###end article-title 86
###begin article-title 87
###xml 75 76 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 113 118 <span type="species:ncbi:9606">human</span>
Using chromatin immunoprecipitation to monitor 1alpha,25-dihydroxyvitamin D3-dependent chromatin activity on the human CYP24 promoter
###end article-title 87
###begin article-title 88
CENSOR- a program for identification and elimination of repetitive elements from DNA sequences
###end article-title 88
###begin article-title 89
TFIIH is negatively regulated by cdk8-containing mediator complexes
###end article-title 89
###begin article-title 90
###xml 18 23 <span type="species:ncbi:9606">human</span>
Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity
###end article-title 91
###begin article-title 92
Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma
###end article-title 92
###begin article-title 93
Looping versus linking: toward a model for long-distance gene activation
###end article-title 93
###begin article-title 94
###xml 14 17 <span type="species:ncbi:10116">rat</span>
Regulation of rat cytochrome P450C24 (CYP24) gene expression
###end article-title 94
###begin article-title 95
Regulation of cytochrome P450 (CYP) genes by nuclear receptors
###end article-title 95
###begin article-title 96
Differential nuclear receptor signalling from DR4-type response elements
###end article-title 96
###begin article-title 97
Characterization of DNA complexes formed by the nuclear receptor constitutive androstane receptor
###end article-title 97
###begin article-title 98
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 125 126 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spp-1</italic>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression
###end article-title 98
###begin title 99
Figures and Tables
###end title 99
###begin p 100
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARP0</italic>
###xml 284 285 284 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 363 364 363 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 412 420 412 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 480 481 476 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 482 483 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 499 500 495 496 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 521 529 517 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 580 581 572 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 582 583 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
Comparison of cyclin C and CYP24 mRNA expression. Real-time quantitative PCR was used to determine the ratio of the basal levels of cyclin C and CYP24 mRNA relative to the control gene ARP0 in MCF-7 and MDA-MB453 human breast cancer and in LNCaP and PC-3 human prostate cancer cells (A). A logarithmic scale is employed on the y-axis to better present the data. (B) In the same four cell lines, the induction of cyclin C and CYP24 mRNA after 2 h treatment with 10 nM 1alpha,25(OH)2D3 was measured. (C) The time course of cyclin C mRNA expression in response to 10 nM 1alpha,25(OH)2D3 was determined in MCF-7 cells. Data points (A and C) and columns (B) indicate the means of at least three independent cell treatments and the bars represent the standard error of mean. The standard deviations in (A) are too small to be visible in relationship with the data points.
###end p 100
###begin p 101
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 165 166 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 167 168 163 164 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 331 339 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 456 461 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 489 490 485 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 532 533 528 529 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 325 330 <span type="species:ncbi:9606">human</span>
Chromatin activity of the human cyclin C promoter. Chromatin was extracted from MCF-7 cells that had been treated for indicated time periods with 10 nM 1alpha,25(OH)2D3. ChIP assays using an antibody against AcH4 were performed. The histone 4 acetylation states of 23 overlapping regions representing the first 8.4 kb of the human cyclin C promoter was monitored for the five treatment times in comparison with the activity of the proximal promoter of the CYP24 gene (promoter region 1). (A) Representative agarose gels are shown. (B) The basal activity of the promoter regions (time point 0 min) was determined by quantifying the ethidium bromide-stained PCR products on a FLA-3000 reader in relationship with the chromatin input. Columns indicate the means of at least six independent cell treatments and the bars represent standard error of mean.
###end p 101
###begin p 102
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 183 184 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 185 186 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 231 232 227 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 243 244 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 321 329 317 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 437 442 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
Ligand-modulated VDR and RXR binding to the human cyclin C promoter. Chromatin was extracted from MCF-7 cells that had been treated for indicated time periods with 10 nM 1alpha,25(OH)2D3. ChIP assays using an antibody against VDR (A) and RXR (B) were performed. The VDR and RXR association of the 23 regions of the human cyclin C promoter was monitored for the six treatment times in comparison with that of the proximal promoter of the CYP24 gene (promoter region 1). Representative agarose gels are shown.
###end p 102
###begin p 103
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 56 64 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 79 88 79 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 187 195 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 365 366 365 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 410 418 410 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 501 503 501 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 816 821 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 866 867 866 867 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 430 435 <span type="species:ncbi:9606">human</span>
###xml 444 449 <span type="species:ncbi:9606">human</span>
In silico and in vitro screening for VDREs in the human cyclin C promoter. (A) In silico promoter analysis indicated nine putative VDREs (RE1-RE9) found within seven regions of the human cyclin C promoter. The two hexameric half sites of each VDRE core sequence are shown in boldface and their relative orientation and number of spacing nucleotides are indicated. (B) Gel-shift experiments were performed with in vitro translated human VDR and human RXR alone or in combination and in the presence of 32P-labeled REs. Protein-DNA complexes were resolved from free probe through non-denaturing 8% polyacrylamide gels. Representative gels are shown. The relative amount of VDR-RXR heterodimer complex formation was quantified on a FLA-3000 reader in relationship with the DR3-type VDRE of the proximal promoter of the CYP24 gene. NS indicates non-specific complexes. (C) The order and the results of the screening procedure are schematically depicted in a flow chart.
###end p 103
###begin p 104
###xml 132 142 132 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">luciferase</italic>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANF</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pit-1</italic>
###xml 288 289 288 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 323 331 323 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 439 440 439 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 553 554 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 555 556 551 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 232 235 <span type="species:ncbi:10116">rat</span>
###xml 272 275 <span type="species:ncbi:10116">rat</span>
###xml 317 322 <span type="species:ncbi:9606">human</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
Functionality of VDREs. Reporter gene assays were performed with extracts from MCF-7 cells that were transiently transfected with a luciferase reporter construct containing two copies of RE2, RE5, RE7, RE8, the DR3-type VDRE of the rat ANF gene and the DR4-type RE of the rat pit-1 gene (A) or 390 bp fragment of the human cyclin C promoter containing RE2 and a comparable fragment of the human CYP24 promoter including the DR3-type VDRE (B) and an expression vector for human VDR. Cells were treated for 16 h with either solvent or 100 nM 1alpha,25(OH)2D3. Relative luciferase activity is shown and fold inductions are indicated above the columns. Columns represent means of at least three experiments and bars indicate standard deviations.
###end p 104
###begin p 105
###xml 30 31 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 32 33 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 177 178 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 179 180 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 455 463 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin C</italic>
###xml 484 485 476 477 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 492 493 484 485 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 519 520 511 512 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 527 528 519 520 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 535 536 527 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 558 563 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24</italic>
###xml 574 575 566 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 449 454 <span type="species:ncbi:9606">human</span>
VDR complexes in 1alpha,25(OH)2D3-responsive promoter regions. Chromatin was extracted from MCF-7 cells that had been treated for indicated time periods with 10 nM 1alpha,25(OH)2D3. Re-ChIP experiments were performed with a first immuno-precipitation with anti-VDR antibody and a second precipitation with anti-RXR, anti-NCoA3, anti-MED1 or anti-phosphorylated Pol II antibodies. The association of VDR and its partner proteins was monitored on the human cyclin C promoter regions 6 (A), 11 (B) (negative control), 16 (C), 20 (D), 23 (E) and region 1 of the CYP24 promoter (F) (positive control). Representative agarose gels are shown.
###end p 105
###begin p 106
###xml 59 64 <span type="species:ncbi:9606">human</span>
Genomic PCR primer sequences and their location within the human cyclin C and CYP24 promoters
###end p 106

